Colin Biggin
Förmögenhet: 7 M $ per 2026-09-30
Förmögenhet: 7 M $ per 2026-09-30
Colin Biggin is currently a Member at The Royal Society of Chemistry and the Society of Nuclear Medicine & Molecular Imaging.
Since 2017, Dr. Biggin has been Chief Operating Officer at Clarity Pharmaceuticals Ltd., with the COO title starting in 2026.
Dr. Biggin completed undergraduate and doctorate degrees at the University of Glasgow.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-08 | 4 926 458 ( 1,32 % ) | 7 M $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Verksamhetschef | 2024-10-11 |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Företagsledare/Principal | - |
Society of Nuclear Medicine & Molecular Imaging
Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
Society of Nuclear Medicine & Molecular Imaging
Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging | Commercial Services |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån